Showing results (281-290 of 461) with videos related to
Sort By:
Pageof 47
American Journal of Hematology|November 23, 2013
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapyTaxiarchis V Kourelis, Shaji K Kumar, Geetika Srivastava, et al.Leukemia & Lymphoma|October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status reportMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.American Journal of Hematology|July 18, 2018
Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal proteinMarcella Tschautscher, Vincent Rajkumar, Angela Dispenzieri, et al.Anti-Cancer Drugs|April 17, 2023
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myelomaMuhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, et al.Blood|May 24, 2013
Outcomes of patients with POEMS syndrome treated initially with radiationMichael S Humeniuk, Morie A Gertz, Martha Q Lacy, et al.American Journal of Hematology|December 16, 2020
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myelomaJoselle Cook, Isla Johnson, Alexandra Higgins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2013
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myelomaPrashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.Clinical Lymphoma, Myeloma & Leukemia|September 15, 2016
Myelomatous Involvement of the Central Nervous SystemJonas Paludo, Utkarsh Painuly, Shaji Kumar, et al.Blood Cancer Journal|August 17, 2023
Long-term outcomes of allogeneic stem cell transplant in multiple myelomaWalker M Schmidt, Nirosha D Perera, Francis K Buadi, et al.Pageof 47